SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021.

Yoshihiro Takayama; Yusuke Shimakawa; Yoshiaki Aizawa; Christian Butcher; Naomi Chibana; Mary Collins; Kohei Kamegai; Tae Gyun Kim; Satoshi Koyama; Ryota Matsuyama; Melissa M. Matthews; Tomoari Mori; Tetsuharu Nagamoto; Masashi Narita; Ryosuke Omori; Norio Shibata; Satoshi Shibata; Souichi Shiiki; Shunichi Takakura; Naoki Toyozato; Hiroyuki Tsuchiya; Matthias Wolf; Taro Yamamoto; Shuhei Yokoyama; Sho Yonaha; Kenji Mizumoto

doi:10.7883/yoken.jjid.2023.255

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

We estimated the seroprevalence of anti-SARS-COV-2 IgG in different island groups in Okinawa. A cross-sectional sero-survey was repeated in three periods between July 2020 and February 2021. A total of 2683 serum samples were collected from six referral medical centers, each covering a separate region in Okinawa. In the main island, the seroprevalence was 0.0% (0/392, 95% CI: 0.0-0.9), 0.6% (8/1448, 0.2-1.1), and 1.4% (8/582, 0.6-2.7) at the 1

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Takayama et al. (2024) studied this question.

synapsesocial.com/papers/68e57074b6db643587511531 https://doi.org/10.7883/yoken.jjid.2023.255

View Full Paper

Ask AI

Bookmark

Share

SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021.

Ask about this paper

Abstract

Discussion

Cite This Study

SARS-CoV-2 IgG seroprevalence in the Okinawa Main Island and remote islands in Okinawa, Japan, 2020-2021.

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading